Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Perosphere Pharmaceuticals Inc, A Wholly Owned Subsidiary Of Amag Pharmaceuticals, Inc.

Clinical trials sponsored by Perosphere Pharmaceuticals Inc, A Wholly Owned Subsidiary Of Amag Pharmaceuticals, Inc., explained in plain language.

Completed 2
Sort by
  • New antidote for blood thinner shows promise in early trial

    Disease control Completed

    This study tested an investigational drug called ciraparantag to see if it can quickly reverse the effects of the blood thinner rivaroxaban. Sixty-nine healthy adults aged 50 to 75 took rivaroxaban and then received either ciraparantag or a placebo. The main goal was to measure h…

    Phase: PHASE2 • Sponsor: Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. • Aim: Disease control

    Last updated May 26, 2026 07:52 UTC

  • New antidote for blood thinner shows promise in early trial

    Disease control Completed

    This study tested a drug called ciraparantag to see if it could quickly reverse the effects of the blood thinner apixaban. Sixty healthy adults aged 50 to 75 took part. The goal was to bring blood clotting time back to normal within an hour and keep it stable for several hours.

    Phase: PHASE2 • Sponsor: Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. • Aim: Disease control

    Last updated May 22, 2026 13:50 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space